Vanda Pharmaceuticals buy marge
Start price
30.10.17
/
50%
€14.03
Target price
04.11.21
€18.86
Performance (%)
11.22%
End price
05.11.21
€15.60
Summary
This prediction ended on 05.11.21 with a price of €15.60. The prediction had a final performance of 11.22%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vanda Pharmaceuticals | -4.696% | -4.696% | 55.688% | 3.246% |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% | 49.858% |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% | 100.330% |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% | 65.355% |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% | 68.657% |
Comments by marge for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda mit positiven Analystenkommentaren
- Vanda Pharmaceuticals (NASDAQ:VNDA) price target raised to $26 (77% upside) from $21 by Oppenheimer citing more bullish forecasts for Hetlioz (Outperform).
Kursziel geändert auf 18,864
In the thread Trading Vanda Pharmaceuticals
Die von marge gewählte maximale Laufzeit wurde überschritten